EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Human T cells from resistant hypertension patients promote hypertension via tumour necrosis factor in humanized mice

Masudur Rahman, Hendrik Bartolomaeus, Lydia Hering, Mina Yakoub, Guang Yang, Johannes Holle iD, Lukas Streese, Denada Arifaj, Milena Hahn, Marta Kantauskaite, Tim F Grüner, Jaroslawna Meister und 6 weitere

Cardiovascular Research · 24.10.2026

DOI: 10.1093/cvr/cvag246 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cardiovascular Research, online erschienen am 24.10.2026. Verfasst von Masudur Rahman und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Faculty of Medicine, University Hospital, Heinrich-Heine-University, Düsseldorf, Germany. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: German Research Foundation, Erben-Felder-Stiftung.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Preclinical studies suggest a pivotal role of adaptive immunity, particularly T cells, in hypertension. However, due to the multifactorial pathogenesis, there is still no definitive evidence for a causal role of T cells in the development of hypertension in humans. We sought to determine whether T cells from patients with treatment-resistant hypertension (TRH) directly modulate blood pressure and vascular function in vivo. Methods and results Peripheral blood mononuclear cells (PBMCs) from TRH patients and healthy controls (HCs) were adoptively transferred into immunodeficient NSG-(KbDb)null mice. Hypertension was induced by angiotensin II infusion for 14 days and monitored continuously by radiotelemetry. Following T cell engraftment, blood pressure was assessed at baseline and during AngII infusion in both groups of recipient mice. At baseline, systolic blood pressure did not differ between the two groups. However, mice receiving TRH-PBMCs developed a significantly higher systolic blood pressure following AngII compared with HC-PBMC recipients. Endothelial dysfunction in isolated perfused kidneys was more pronounced in AngII-challenged TRH-PBMC recipients compared to HC-PBMC recipients. TRH-PBMC recipients displayed elevated effector memory CD4+ T cells and Th17 frequencies in spleen and kidney, along with markedly increased renal expression of human T cell-derived tumour necrosis factor (TNF). Overnight incubation of mouse aortic rings with human TNF induced endothelial dysfunction, indicating a causal role of T cell-derived TNF. As a proof of concept, TNF inhibition attenuated AngII-induced hypertension in TRH-PBMC–engrafted mice.

Conclusion

T cells from patients with TRH promote an exaggerated hypertensive response and endothelial dysfunction in PBMC-engrafted humanized mice, promoted by TNF-mediated mechanisms. These findings provide evidence that T cell–derived TNF may contribute to the pathogenesis of human hypertension.

Schlagwörter

Stichwörter der Autor:innen

T cell-derived TNFadaptive immunityendothelial dysfunctionhumanized mouse modeltreatment-resistant hypertension

Autor:innen und Institutionen

  • Department of Nephrology, Faculty of Medicine, University Hospital, Heinrich-Heine-University, Düsseldorf, Germany.
  • Institute of Experimental Biomedicine, University Hospital Würzburg, Germany.
  • Division of Nephrology, Peking University Shenzhen Hospital, China.
  • Department of General Pediatrics and Hematology/Oncology, University Children's Hospital, University Hospital Tübingen, Germany.
  • Faculty of Health Care, Niederrhein University of Applied Sciences, Krefeld, Germany.
  • Institute for Clinical Diabetology, German Diabetes Center, Leibniz Institute for Diabetes Research at Heinrich Heine University, Düsseldorf, Germany.

ORCID-Profile: Johannes Holle, Nicola Wilck, Johannes Stegbauer

Förderung

  • German Research Foundation
  • Erben-Felder-Stiftung

Zitieren

APA

Rahman, M., Bartolomaeus, H., Hering, L., Yakoub, M., Yang, G., Holle, J., Streese, L., Arifaj, D., Hahn, M., Kantauskaite, M., Grüner, T. F., Meister, J., Wilck, N., Kleinewietfeld, M., Rump, L. C., Müller, D. N., Temme, S., & Stegbauer, J. (2026). Human T cells from resistant hypertension patients promote hypertension via tumour necrosis factor in humanized mice. Cardiovascular Research. https://doi.org/10.1093/cvr/cvag246

Vancouver

Rahman M, Bartolomaeus H, Hering L, Yakoub M, Yang G, Holle J, et al. Human T cells from resistant hypertension patients promote hypertension via tumour necrosis factor in humanized mice. Cardiovascular Research. 2026. doi:10.1093/cvr/cvag246

BibTeX
@article{Rahman2026,
  author = {Rahman, Masudur and Bartolomaeus, Hendrik and Hering, Lydia and Yakoub, Mina and Yang, Guang and Holle, Johannes and Streese, Lukas and Arifaj, Denada and Hahn, Milena and Kantauskaite, Marta and Grüner, Tim F and Meister, Jaroslawna and Wilck, Nicola and Kleinewietfeld, Markus and Rump, Lars C and Müller, Dominik N and Temme, Sebastian and Stegbauer, Johannes},
  title = {Human T cells from resistant hypertension patients promote hypertension via tumour necrosis factor in humanized mice},
  journal = {Cardiovascular Research},
  year = {2026},
  doi = {10.1093/cvr/cvag246}
}
Kostenlos starten →